Research Topics
| Steven MorganSummaryAffiliation: University of British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provincesSteven G Morgan
Centre for Health Services and Policy Research, School of Population and Public Health, Faculty of Medicine, University of British Columbia, 201 2206 East Mall, Vancouver V6T 1Z3, Canada
BMC Health Serv Res 13:34. 2013..abstract:..
Income inequities in end-of-life health care spending in British Columbia, Canada: A cross-sectional analysis, 2004-2006Colleen M Cunningham
Centre for Health Services and Policy Research, University of British Columbia, 201 2206 East Mall, Vancouver B, C, V6T1Z3 Canada
Int J Equity Health 10:12. 2011..abstract:..
Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy researchDevon L Greyson
Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, 201 2206 East Mall, Vancouver, BC, V6T1Z3, Canada
Int J Equity Health 9:26. 2010..A growing number of research bodies internationally have issued laws, guidance or encouragement to support conducting sex and gender based analysis (SGBA) in all health related research...
Effects of prescription adaptation by pharmacistsMichael R Law
Centre for Health Services and Policy Research, School of Population and Public Health, The University of British Columbia, 201 2206 East Mall, Vancouver, BC, V6T 1Z3, Canada
BMC Health Serv Res 10:313. 2010..We hypothesize this policy increased drug utilization and drug costs, increased patient adherence to medication, and reduced total healthcare resource use...
Registration for public drug benefits across areas of differing ethnic composition in British Columbia, CanadaVivian W Leong
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, Canada
BMC Health Serv Res 10:171. 2010..Given past research suggesting that registration processes may pose an access barrier to certain subpopulations, we aimed to determine whether registration rates varied across small geographic areas that differed in ethnic composition...
On the validity of area-based income measures to proxy household incomeGillian E Hanley
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC Canada
BMC Health Serv Res 8:79. 2008....
Booming prescription drug expenditure: a population-based analysis of age dynamicsSteven G Morgan
Centre for Health Services and Policy Research, Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
Med Care 43:996-1008. 2005..Prescription drug expenditures in North America have nearly doubled in the past 5 years, creating intense pressure for all public and private benefits managers and policymakers...
Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdomSteven G Morgan
University of British Columbia
Health Aff (Millwood) 25:337-47. 2006..Rigor of process and transparency of data and rationale are believed to be important for maximizing the impact and political acceptability of the processes...
Centralising drug review to improve coverage decisions: economic lessons from (and for) CanadaSteve Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia, Canada
Appl Health Econ Health Policy 5:67-73. 2006....
Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from AustraliaSteve Morgan
Centre for Health Services and Policy Research, Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC, Canada
Health Policy 87:133-45. 2008..Australia has grappled with this issue for years, even incorporating the goal of "maintaining a responsible and viable medicines industry" into its National Medicines Policy...
Individual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British ColumbiaSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia, Canada
PLoS ONE 5:e15883. 2010..In this paper, we explore the determinants of variations in the use of prescription drugs, drawing on health services theories of access to care...
Income-based drug coverage in British Columbia: the impact on private and public expendituresSteve Morgan
Department of Health Care and Epidemiology, Program in Pharmaceutical Policy, Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC
Healthc Policy 2:e129-53. 2006..It was also hoped that income-based deductibles would increase consumer price sensitivity in decision-making. This analysis measured policy impacts on private and public expenditure and on expenditure drivers...
Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative dataSteven Morgan
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
Open Med 5:e87-93. 2011..We conducted a cross-sectional analysis of survey and administrative data to examine needs-adjusted rates of prescription drug use by people of different ethnic groups...
Prescription drug accessibility and affordability in the United States and abroadSteve Morgan
School of Population and Public Health, University of British Columbia, Canada
Issue Brief (Commonw Fund) 89:1-12. 2010..The authors say that value-based benefit designs, reference pricing, and group purchasing could reduce financial barriers and keep down pharmaceutical spending...
The cost of drug development: a systematic reviewSteve Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, Canada
Health Policy 100:4-17. 2011..We aimed to systematically review and assess published estimates of the cost of developing new drugs...
"Breakthrough" drugs and growth in expenditure on prescription drugs in CanadaSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia, 429-2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
BMJ 331:815-6. 2005
Canadian prescription drug costs surpass 18 billion dollarsSteve Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC
CMAJ 172:1323-4. 2005
Predictive genetic tests and health system costsSteve Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC
CMAJ 168:989-91. 2003
Seniors' prescription drug cost inflation and cost containment: evidence from British ColumbiaSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
Health Policy 68:299-307. 2004..Changes in the mix of therapies and the type of product selected explained over half of the observed drug expenditure inflation. Increased generic substitution significantly reduced the price of products selected over the period...
Outcomes-based drug coverage in British ColumbiaSteven Morgan
University of British Columbia, Health Care and Epidemiology, Program in Pharmaceutical Policy, Centre for Health Services and Policy Research
Health Aff (Millwood) 23:269-76. 2004..We describe lessons from the B.C. experience for jurisdictions interested in basing coverage on evidence of proven comparative advantage for patients' health...
Drug spending in Canada: recent trends and causesSteve Morgan
Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
Med Care 42:635-42. 2004..Canadians spent almost dollars 15 billion, over dollars 460 per capita, on prescription drugs in 2002, yet there is little published evidence regarding the nature and causes of these expenditures...
An outcomes-based approach to decisions about drug coverage policies in British ColumbiaSteve Morgan
Program in Pharmaceutical Policy, Centre for Health Services and Policy Research, University of British Columbia, 429-2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
Psychiatr Serv 55:1230-2. 2004
First-line first? Trends in thiazide prescribing for hypertensive seniorsSteve Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, Canada
PLoS Med 2:e80. 2005....
Persistence with hypertension treatment among community-dwelling BC seniorsSteven G Morgan
Centre for Health Services and Policy Research, UBC
Can J Clin Pharmacol 11:e267-73. 2004..The purpose of this study was to examine persistence with prescribed hypertension treatment among newly treated community-dwelling seniors in British Columbia...
The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?Steven Morgan
Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, V6T 1Z3, Canada
J Health Serv Res Policy 8:237-44. 2003....
Internet pharmacy: prices on the up-and-upSteven Morgan
Centre for Health Services and Policy Research, Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC
CMAJ 170:945-6. 2004
Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in british columbia, 1996 to 2006Steven Morgan
Associate Professor and Associate Director, Centre for Health Services and Policy Research, School of Population and Public Heath, University of British Columbia, Vancouver, Canada
Healthc Policy 7:68-79. 2011....
Quantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit planSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver
Health Serv Res 37:1243-66. 2002..CONCLUSIONS: The results suggest that drug plans (and patients) would benefit from more concerted efforts to evaluate the relative cost-effectiveness of competing products within therapeutic categories of drugs...
Whither seniors' pharmacare: lessons from (and for) CanadaSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia
Health Aff (Millwood) 22:49-59. 2003..Sustainable and equitable pharmacare programs require the political willingness to confront opposition to policies that will, if successful, contain program costs without obstructing access...
Post-Romanow pharmacare: last-dollar first...first-dollar lost?Steven G Morgan
Health Care and Epidemiology, Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia, Canada
Healthc Pap 4:10-20. 2004....
The authors respondSteven G Morgan
Health Care and Epidemiology, and Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia, Canada
Healthc Pap 4:68-72. 2004....
Canadians confront health care reformJulia Abelson
Department of Clinical Epidemiology and Biostatistics, Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Ontario
Health Aff (Millwood) 23:186-93. 2004..But they appeared more receptive to two-tier care and for-profit delivery for the newer and rapidly expanding domains of home care and high-tech care...
Prescription drug expenditures and population demographicsSteven G Morgan
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC Canada V6T 1Z3
Health Serv Res 41:411-28. 2006..The sustainability of drug spending therefore depends not on outside forces but on decisions made by policy makers, prescribers, and patients...
Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs?Megan E Coombes
Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, BC V6T 1Z3
Healthc Q 7:suppl 13-9. 2004..A national standard for "reasonable" catastrophic coverage has yet to be formally defined...
Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilizationPatricia A Caetano
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, British Columbia
Clin Ther 28:1411-24; discussion 1410. 2006..However, the terminology and methodology used for measuring persistence varied across studies, making it difficult to compare persistence rates...
A population-based analysis of statin utilization in British ColumbiaColette B Raymond
University of Manitoba, Faculty of Pharmacy, Department of Pharmaceutical Services Health Sciences Centre, Winnipeg, Manitoba, Canada
Clin Ther 29:2107-19. 2007..The purpose of this research was to measure prevalent and incident statin use in the population of British Columbia from 1996 to 2004 across specific patient characteristics (sociodemographic and clinical)...
Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidenceColette B Raymond
Department of Pharmaceutical Services, Health Sciences Centre Hospital, Winnipeg, Manitoba, Canada
Psychiatr Serv 58:79-84. 2007..This study investigated the prevalence and incidence of antidepressant use in British Columbia over eight years...
